Profile | GDS4284 / 243860_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 815.442 | 71 |
GSM687648 | Patient 402 control | 589.892 | 66 |
GSM687653 | Patient 403 control | 883.726 | 73 |
GSM687658 | Patient 404 control | 507.998 | 64 |
GSM687663 | Patient 411 control | 1105.09 | 75 |
GSM687668 | Patient 422 control | 720.337 | 69 |
GSM687673 | Patient 424 control | 643.724 | 67 |
GSM687678 | Patient 425 control | 1170.13 | 76 |
GSM687683 | Patient 427 control | 1250.97 | 77 |
GSM687688 | Patient 428 control | 1026.13 | 74 |
GSM687695 | Patient 441 control | 211.528 | 40 |
GSM687699 | Patient 443 control | 936.122 | 73 |
GSM687704 | Patient 444 control | 1053 | 75 |
GSM687707 | Patient 448 control | 577.97 | 66 |
GSM687712 | Patient 449 control | 573.475 | 66 |
GSM687719 | Patient 450 control | 601.237 | 65 |
GSM687724 | Patient 451 control | 1125.33 | 76 |
GSM687728 | Patient 452 control | 1384.2 | 79 |
GSM687646 | Patient 401 treated 24h | 901.059 | 72 |
GSM687649 | Patient 402 treated 24h | 736.213 | 69 |
GSM687665 | Patient 411 treated 24h | 811.947 | 70 |
GSM687651 | Patient 402 treated 4 weeks | 865.651 | 71 |
GSM687667 | Patient 411 treated 4 weeks | 881.78 | 72 |
GSM687670 | Patient 422 treated 24h | 613.132 | 66 |
GSM687671 | Patient 422 treated 4 weeks | 680.754 | 68 |
GSM687654 | Patient 403 treated 24h | 1013.21 | 74 |
GSM687675 | Patient 424 treated 24h | 377.169 | 58 |
GSM687685 | Patient 427 treated 24h | 1325.08 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 764.229 | 70 |
GSM687677 | Patient 424 treated 4 weeks | 1038.41 | 74 |
GSM687687 | Patient 427 treated 4 weeks | 1222.5 | 77 |
GSM687692 | Patient 428 treated 4h | 676.451 | 68 |
GSM687716 | Patient 449 treated 4h | 810.054 | 71 |
GSM687722 | Patient 450 treated 4h | 779.819 | 70 |
GSM687680 | Patient 425 treated 24h | 1216.9 | 77 |
GSM687690 | Patient 428 treated 24h | 636.841 | 68 |
GSM687700 | Patient 443 treated 24h | 993.223 | 73 |
GSM687705 | Patient 444 treated 24h | 1344.87 | 78 |
GSM687714 | Patient 449 treated 24h | 573.09 | 66 |
GSM687721 | Patient 450 treated 24h | 325.007 | 54 |
GSM687682 | Patient 425 treated 4 weeks | 1566.39 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 616.524 | 67 |
GSM687702 | Patient 443 treated 4 weeks | 717.713 | 68 |
GSM687718 | Patient 449 treated 4 weeks | 676.81 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 609.828 | 66 |
GSM687661 | Patient 404 treated 4h | 525.66 | 64 |
GSM687710 | Patient 448 treated 4h | 934.83 | 74 |
GSM687726 | Patient 451 treated 4h | 1435.61 | 79 |
GSM687730 | Patient 452 treated 4h | 1383.8 | 80 |
GSM687660 | Patient 404 treated 24h | 339.209 | 56 |
GSM687697 | Patient 441 treated 24h | 1070.42 | 76 |
GSM687709 | Patient 448 treated 24h | 616.97 | 67 |
GSM687725 | Patient 451 treated 24h | 803.584 | 71 |
GSM687729 | Patient 452 treated 24h | 578.826 | 66 |
GSM687727 | Patient 451 treated 4 weeks | 3315.18 | 90 |
GSM687731 | Patient 452 treated 4 weeks | 688.457 | 68 |